These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 5040107)
1. Rifampin: clinical experience with a new anti-tuberculosis drug. Raleigh JW Trans Am Clin Climatol Assoc; 1972; 83():104-12. PubMed ID: 5040107 [No Abstract] [Full Text] [Related]
2. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Shah AR; Agarwal SK; Shah KV Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118 [TBL] [Abstract][Full Text] [Related]
8. Intermittent chemotherapy or improvement of initial treatment in tuberculosis. Oka S Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334 [No Abstract] [Full Text] [Related]
9. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy]. Freerksen E Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222 [No Abstract] [Full Text] [Related]
10. [New guidelines for pulmonary tuberculosis therapy]. Steiner A; Medici TC Dtsch Med Wochenschr; 1978 Mar; 103(9):372-5. PubMed ID: 631063 [No Abstract] [Full Text] [Related]
11. [A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)]. Kameda K; Kino C Kekkaku; 1974 Nov; 49(11):387-91. PubMed ID: 4455991 [No Abstract] [Full Text] [Related]
12. Practical application of short-course (6 month) regimens of chemotherapy for pulmonary tuberculosis in Kenyan nomads. Aluoch JA East Afr Med J; 1979 Mar; 56(3):121-6. PubMed ID: 487976 [No Abstract] [Full Text] [Related]
14. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Mitchison DA Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106 [TBL] [Abstract][Full Text] [Related]
15. [Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis]. Szymański A Pneumonol Pol; 1976 Mar; 44(3):227-35. PubMed ID: 1257096 [No Abstract] [Full Text] [Related]
16. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis. Kradolfer F; Schnell R Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314 [No Abstract] [Full Text] [Related]
17. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis. Pandey R; Sharma S; Khuller GK Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096 [No Abstract] [Full Text] [Related]
18. Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study. Favez G; Chioléro R; Willa C Chest; 1972 Jun; 61(6):583-6. PubMed ID: 4624280 [No Abstract] [Full Text] [Related]
19. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548 [No Abstract] [Full Text] [Related]
20. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity]. Ubaĭdullaev AM; Belotserkovets VG Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]